Hong Kong: M&A/Private Equity

Herbert Smith Freehills Kramer’s quarterly review of private capital buyouts, fundraising and disputes tells a familiar story for the first half of 2026: subdued on-market play with flashes of brilliance.

A quiet first half for Asia private capital, with both fundraising and buyout activity subdued, and no indication whether a second-half rebound will materialise as in recent years.

Ankura presents a curated collection of strategic insights spanning IPO scrutiny in Hong Kong, private credit risk assessment, corporate valuation in litigation, tariff-related class actions, and healthcare transaction trends. These featured analyses examine how regulatory shifts, geopolitical volatility, and emerging technologies are reshaping risk management, compliance strategies, and business operations across global markets.

Gagging orders are court orders restraining persons from revealing or disclosing information about proceedings...

On 23 May 2025 the new Hong Kong redomiciliation regime for insurers became effective through amendments to the Companies Ordinance, Insurance Ordinance and other laws and guidelines.

On 1 August 2025, the Stock Exchange of Hong Kong Limited (the "Exchange") published the consultation conclusion1 ("Conclusion") on its proposals to optimise IPO price discovery and open market requirements...

The August 2022 amendments to the Antimonopoly Law introduced a new "stop-the-clock" mechanism in the merger review process. This mechanism allows the antimonopoly enforcement authority

Certain provisions of the current Codes on Takeovers and Mergers and Share Buybacks of Hong Kong (the "Codes") may cause confusion to companies and relevant stakeholders in complying with the Codes.

The Hong Kong Securities & Futures Commission (SFC) recently published a Consultation Paperi proposing a wide range of amendments to the Codes on Takeovers and Mergers and Share Buy-backs...